ArticleCancer2017

Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric/gastroesophageal junction adenocarcinomas: A survival analysis of 5058 patients.

Timothy L Fitzgerald et al.PubMed ↗Publisher ↗

No numbers read from the abstract.